Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamil Mayet

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Journal of the American College of Cardiology|March 19, 2013
Diagnostic classification of the instantaneous wave-free ratio is equivalent to fractional flow reserve and is not improved with adenosine administration. Results of CLARIFY (Classification Accuracy of Pressure-Only Ratios Against Indices Using Flow Study)Sayan Sen, Kaleab N Asrress, Sukhjinder Nijjer, et al.
Perfusion|January 11, 2021
Adapting the role of handheld echocardiography during the COVID-19 pandemic: A practical guideHafiz Naderi, Shaun Robinson, Martin J Swaans, et al.
Heart (British Cardiac Society)|June 9, 2026
Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairmentDidier Collard, Yang Chen, Amit Kaura, et al.
Lancet (London, England)|November 7, 2017
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trialRasha Al-Lamee, David Thompson, Hakim-Moulay Dehbi, et al.
Journal of the American Heart Association|March 28, 2020
Prognostic significance of troponin level in 3121 patients presenting with atrial fibrillation (The NIHR Health Informatics Collaborative TROP-AF study)Amit Kaura, Ahran D Arnold, Vasileios Panoulas, et al.
Lancet (London, England)|August 23, 2011
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trialJohn G F Cleland, John R Teerlink, Roxy Senior, et al.
JACC. Cardiovascular Interventions|December 3, 2014
Pre-angioplasty instantaneous wave-free ratio pullback provides virtual intervention and predicts hemodynamic outcome for serial lesions and diffuse coronary artery diseaseSukhjinder S Nijjer, Sayan Sen, Ricardo Petraco, et al.
Lancet (London, England)|August 31, 2020
Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical dataAmit Kaura, Jonathan A C Sterne, Adam Trickey, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 13, 2023
The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD ReadmissionsConstantinos Kallis, Amit Kaura, Nathan A Samuel, et al.
JACC. Cardiovascular Imaging|May 21, 2018
Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO TrialZachary I Whinnett, S M Afzal Sohaib, Mark Mason, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Journal of the American College of Cardiology|March 19, 2013
Diagnostic classification of the instantaneous wave-free ratio is equivalent to fractional flow reserve and is not improved with adenosine administration. Results of CLARIFY (Classification Accuracy of Pressure-Only Ratios Against Indices Using Flow Study)Sayan Sen, Kaleab N Asrress, Sukhjinder Nijjer, et al.
Perfusion|January 11, 2021
Adapting the role of handheld echocardiography during the COVID-19 pandemic: A practical guideHafiz Naderi, Shaun Robinson, Martin J Swaans, et al.
Heart (British Cardiac Society)|June 9, 2026
Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairmentDidier Collard, Yang Chen, Amit Kaura, et al.
Lancet (London, England)|November 7, 2017
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trialRasha Al-Lamee, David Thompson, Hakim-Moulay Dehbi, et al.
Journal of the American Heart Association|March 28, 2020
Prognostic significance of troponin level in 3121 patients presenting with atrial fibrillation (The NIHR Health Informatics Collaborative TROP-AF study)Amit Kaura, Ahran D Arnold, Vasileios Panoulas, et al.
Lancet (London, England)|August 23, 2011
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trialJohn G F Cleland, John R Teerlink, Roxy Senior, et al.
JACC. Cardiovascular Interventions|December 3, 2014
Pre-angioplasty instantaneous wave-free ratio pullback provides virtual intervention and predicts hemodynamic outcome for serial lesions and diffuse coronary artery diseaseSukhjinder S Nijjer, Sayan Sen, Ricardo Petraco, et al.
Lancet (London, England)|August 31, 2020
Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical dataAmit Kaura, Jonathan A C Sterne, Adam Trickey, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 13, 2023
The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD ReadmissionsConstantinos Kallis, Amit Kaura, Nathan A Samuel, et al.
JACC. Cardiovascular Imaging|May 21, 2018
Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO TrialZachary I Whinnett, S M Afzal Sohaib, Mark Mason, et al.
Pageof 18